Abstract
In this work, we present a switching nonlinear model predictive control (NMPC) algorithm for a dual-hormone artificial pancreas (AP), and we use maximum likelihood estimation (MLE) to identify the model parameters. A dual-hormone AP consists of a continuous glucose monitor (CGM), a control algorithm, an insulin pump, and a glucagon pump. The AP is designed with a heuristic to switch between insulin and glucagon as well as state-dependent constraints. We extend an existing glucoregulatory model with glucagon and exercise for simulation, and we use a simpler model for control. We test the AP (NMPC and MLE) using in silico numerical simulations on 50 virtual people with type 1 diabetes. The system is identified for each virtual person based on data generated with the simulation model. The simulations show a mean of 89.3% time in range (3.9-10 mmol/L) and no hypoglycemic events.
Originalsprog | Engelsk |
---|---|
Tidsskrift | IFAC-PapersOnLine |
Vol/bind | 55 |
Udgave nummer | 7 |
Sider (fra-til) | 915-921 |
Antal sider | 7 |
ISSN | 2405-8963 |
DOI | |
Status | Udgivet - 2022 |
Begivenhed | 13th IFAC Symposium on Dynamics and Control of Process Systems, including Biosystems, DYCOPS 2022 - Busan, Sydkorea Varighed: 14 jun. 2022 → 17 jun. 2022 |
Konference
Konference | 13th IFAC Symposium on Dynamics and Control of Process Systems, including Biosystems, DYCOPS 2022 |
---|---|
Land/Område | Sydkorea |
By | Busan |
Periode | 14/06/2022 → 17/06/2022 |